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How glucose metabolism enables rapid acquisition of effector function in memory CD8 + T cells remains poorly understood.
Bantug et al. demonstrate that mitochondria-endoplasmic reticulum contact sites are signaling hubs that enable the metabolic reprogramming required for rapid CD8 + T cell recall responses.
INTRODUCTION

Memory CD8 + T cells form the cellular basis for accelerated
protection upon re-exposure to the same pathogen, which is a hallmark of adaptive immunity (Harty and Badovinac, 2008) . Expansion of T cells following activation-and subsequent differentiation into effector and memory populations-is accompanied by reprogramming of metabolic pathway usage (MacIver et al., 2013) . Our group, and others, previously reported that memory CD8 + T cells possess unique metabolic signatures compared to naive and effector T cells (Balmer et al., 2016; Buck et al., 2016; Gubser et al., 2013; O'Sullivan et al., 2014; van der Windt et al., 2012) . Memory CD8 + T cells have increased respiratory capacity compared to naive counterparts (Gubser et al., 2013) . This distinct mitochondrial feature of memory CD8 + T cells has been linked to increased fatty acid oxidation, which contributes to memory CD8 + T cell differentiation and function (O'Sullivan et al., 2014) . Effector memory (EM) CD8 + T cells constitute an important memory cell subset circulating in the blood, from where they are recruited to inflamed tissues or organs (Sallusto et al., 2004; Thome et al., 2014) . Upon exposure to cognate antigen, EM CD8 + T cells are able to rapidly produce key effector molecules, such as IFN-g (Sallusto et al., 1999) . This innate-like ability to elaborate effector function during the immediate early phase of the recall response has been linked to distinct biochemical, signaling, and epigenetic signatures (Farber, 2009; Weng et al., 2012) . We previously demonstrated that a key metabolic feature of EM CD8 + T cells is the induction of Warburg metabolism (aerobic glycolysis) following stimulation (Gubser et al., 2013) . This rapid and stable activation-induced glycolysis of EM CD8 + T cells is dependent on mTORC2-AKT signaling but not mTORC1, which primarily exerts its control on metabolism of activated effector cells (Gubser et al., 2013) . The capacity of EM CD8 + T cells to rapidly produce effector molecules, such as IFN-g, is intricately tied to the fast induction of glycolysis by the mTORC2-AKT pathway (Bantug et al., 2018; Gubser et al., 2013) . Stable glycolysis drives rapid IFN-g production in memory CD8 + T cells at the epigenetic level, by promoting H3K9 acetylation at the IFNG promoter (Gubser et al., 2013) . Recently, IFN-g production by effector T helper 1 (Th1) cells was also shown to be dependent on glycolysis through epigenetic regulation of the Ifng promoter (Peng et al., 2016) . Mitochondrial mass and activity are greater in memory T cells as compared to naive counterparts. However, the role of mitochondrial metabolism, and specifically oxidation of glucosederived pyruvate in mitochondria, during the immediate-early phase of the recall response has not been investigated in any detail. Here we show that activation of AKT by mTORC2 at mitochondria-ER junctions leads to inhibition of GSK3b. This enables binding of HK-I to VDAC and augmentation of mitochondrial respiration. Oxidation of glucose-derived pyruvate in the mitochondria was essential for rapid production of IFN-g, potentially by increasing citrate abundance and providing substrates for histone acetylation.
RESULTS
Memory CD8 + T Cells Rapidly Increase Respiration upon
Activation and Are Enriched for Mitochondria-ER Appositions Distinct metabolic features of memory T cells underpin their ability to rapidly respond to cognate antigen. How mitochondrial respiration in memory CD8 + T cells is altered early following activation remains largely unexplored. Thus, we first examined respiration in non-activated versus nascent activated naive and EM human CD8 + T cells, in vitro. As previously demonstrated, both maximal and spare respiratory capacities were greater in EM than in naive CD8 + T cells under non-activated conditions ( Figure 1A ; Gubser et al., 2013) . Following activation, a noticeable increase in mitochondrial respiration was observed in activated EM CD8 + T cells but not in naive counterparts ( Figure 1A ).
Glycolysis was elevated in both activated CD8 + T cell subsets, with EM cells displaying a more prominent increase than naive cells ( Figure S1A ). Since mitochondrial shape is intricately linked to T cell effector maturation and memory cell survival (Buck et al., 2016) , we also analyzed mitochondrial morphology in human naive and EM CD8 + T cells by electron and confocal microscopy. Electron microscopy images revealed disparities in mitochondrial morphology, with EM cells displaying long, tubular mitochondria, whereas mitochondria in naive cells were more rounded (Figure S1B) . Similarly, morphometric quantification of confocal microscopy images further demonstrated that mitochondria in EM cells possessed longer branch length than naive counterparts ( Figure S1C ). Mitochondrial membrane potential, which was higher in EM cells under basal conditions ( Figure S1D ), was not altered in both subpopulations following stimulation ( Figure S1E ). Mitochondria-ER interactions have been shown to modulate mitochondrial respiration and bioenergetics in non-immune cells (Theurey and Rieusset, 2017) , although the molecular composition of mitochondria-ER tethering complexes in metazoans is not fully defined (Murley and Nunnari, 2016) . In search of additional ultra-structural features that may offer a biologic basis for the contrasting activation-induced respiration phenotypes of naive versus EM CD8 + T cells, we evaluated the abundance of mitochondria-ER contact sites in both subsets. We observed that in naive cells, mitochondria in close association to the ER were sparse ( Figure 1B , top panel, and Figure 1C) . In EM cells, by contrast, the frequency of mitochondria-ER contacts per cell was higher ( Figure 1B , middle panels, and Figure 1C ). The average distance between apposed ER and mitochondrial membranes in EM CD8 + T cells was 21 nm (data not shown). Electrondense zones between the mitochondrial outer membrane and ER at contact sites indicated that these organellar appositions were distinct subcellular structures ( Figure 1B, bottom panel) . To further elaborate on these findings, we performed proximity ligation assays (PLA) to quantify the abundance of mitochondria-ER junctions in naive and EM CD8 + T cell subsets. Mitochondria-ER contacts were detected and enumerated by using a-VDAC1 (mitochondria) and a-IP3R1 (inositol triphosphate receptor 1, ER) antibodies as probes (Tubbs et al., 2014) . Once again, the abundance of mitochondria-ER contact sites was found to be lower in naive cells compared to EM CD8 + T cells ( Figure 1D ). Lastly, naive and EM CD8 + T cells were also labeled with mitochondria (mitotracker deep red) and ER (a-KDEL motif antibody) markers, and the proximity of both organelles was assessed by confocal microscopy. Co-localization of mitochondria with ER was greater in EM cells than naive counterparts (Figure S1F) . In all, these data identified (1) a rapid increase in mitochondrial respiration as a distinct functional feature of EM CD8 + T cells and (2) increased abundance of mitochondrial-ER contacts as a defining structural characteristic of EM CD8 + T cells.
Dissociation of Mitochondria-ER Junctions Attenuates Mitochondrial Respiration in T Cells
In HeLa cells, stable interaction between mitochondria and the ER has been shown to require microtubule polymerization (Bravo et al., 2011) . To determine whether mitochondria-ER junctions were similarly dependent on microtubule polymerization in memory CD8 + T cells, we again used PLA. Activated EM CD8 + T cells exposed to nocodazole, a microtubule polymerization inhibitor, displayed a marked reduction in abundance of mitochondria-ER junctions (Figures 2A and S2A ). We then examined whether these interactions were required for enhancement of mitochondrial respiration in activated memory CD8 + T cells. Nocodazole treatment attenuated the activation-induced increase in mitochondrial respiration (Figures 2B and S2B) . In contrast, nocodazole did not significantly affect glycolysis ( Figure 2B ). To further verify these results, we perturbed mitochondria-ER appositions by treating activated EM CD8 + T cells with the ER stress blocker, 4-PBA, since reduction of ER stress has been shown to reduce mitochondria-ER interaction in non-immune cells (Prasad et al., 2016) . Indeed, mitochondria-ER junctions were also reduced in 4-PBA-treated cells ( Figure S2C ), which again led to a reduction in mitochondrial respiration ( Figure S2D ). Congruent with the above findings, nocodazole treatment also reduced the abundance of mitochondria-ER contacts in Jurkat T cells ( Figure 2C ). Mitochondrial respiration was likewise diminished in nocodazole-treated Jurkat T cells, whereas glycolysis remained unaffected ( Figure 2D ). Lastly, the presence of mitochondria-ER appositions-as well as their sensitivity to dissociation with nocodazole-was also verified in bona fide murine memory CD8 + T cells sorted from mice that had been exposed to Listeria monocytogenes ( Figure S2E ). Next, we examined the molecular composition of mitochondria-ER contact sites in T cells by modifying an established fractionation protocol that enriched for subcellular fractions containing mitochondria as well as ER membranes that are localized to mitochondria-ER junctions (MEJ fraction) (Wieckowski et al., 2009) . To validate the technique, we assessed the abundance of proteins that were previously found to be present at mitochondria-ER contact sites and also probed for mitochondrial, ER, and cytoplasmic proteins in pelleted MEJ fractions from Jurkat T cells, relative to supernatants from these fractions which contain most of the ER, Golgi, and cytoplasm (EGC). In addition, we also compared the MEJ fraction to pure mitochondria (PM) that were isolated using a different technique (Krippner et al., 1996) . As a further control, the presence of all examined proteins was also confirmed in unfractionated total cell lysates (T). ACC, a cytoplasmic protein, was enriched in the EGC fraction but absent from mitochondria-containing fractions (i.e., MEJ and PM) ( Figure 2E ). As expected, the mitochondrial proteins VDAC and COX IV (cytochrome c oxidase, subunit IV) were similarly + T cells left non-activated (non) or activated for 12 hr with plate-bound a-CD3 (5 mg/mL) and soluble a-CD28 (5 mg/mL) mAb (3-28). Mitochondrial perturbation was performed by sequential treatment with oligomycin (Oligo, 1 mM), FCCP (2 mM), and rotenone (Rot, 130 nM). Oxygen consumption rate (OCR) was measured by metabolic flux analysis. Right, summary bar graphs showing calculated basal respiration, maximal respiration (max), and spare respiratory capacity (SRC) in non-activated (-) or activated (+) NV and EM human CD8 + T cells (n = 6 donors).
(B) Transmission electron microscopy images of NV (top) and EM (middle and bottom) human CD8 + T cells. Arrowheads mark mitochondria and ER contact sites that were digitally magnified in the bottom panel (representative of n = 3 donors). Arrows show electron-dense regions of mitochondria-ER junctions. Scale bars, 1,000 nm. (C) Percentage of mitochondria-ER contact sites per cell in NV (n = 15) and EM (n = 13) human CD8 + T cells (n = 3 donors).
(D) Top, representative proximity ligation assay (PLA) images of freshly sorted NV (left) and EM (right) human CD8 + T cells probed with a-IP3R1 and a-VDAC1
antibodies. Red spots indicate contact sites between mitochondria (a-VDAC) and ER (a-IP3R). Cells were counterstained with DAPI (blue). Bottom, quantitative analysis of PLA from 3 donors; NV (n = 72 cells) and EM (n = 73 cells). Data are presented as mean ± SEM. Two-tailed paired Wilcoxon signed rank tests (A) and two-tailed unpaired Student's t test (C and D) were used to compare groups. *p < 0.05, ****p < 0.0001, ns, not significant. See also Figure S1 . present in MEJ and PM fractions ( Figure 2E ). GRP75 (also known as HSPA9), a protein that acts as a molecular tether between mitochondria and ER by associating with VDAC and IP3R (Szabadkai et al., 2006) , was detected in both mitochondria-containing fractions (i.e., MEJ and PM), indicating that GRP75 was primarily associated with mitochondria ( Figure 2E ). By contrast, phosphofurin acidic cluster sorting protein 2 (PACS2), another mitochondria-ER tethering protein that is predominantly located on the ER side of the junction (Myhill et al., 2008) , was more abundant in the MEJ fraction than in pure mitochondria (Figure 2E) . Both mitochondria markers, as well as GRP75, were not detected in the EGC fraction, while PACS2 and proteins containing the KDEL motif-which is a retention signal for ER-localized proteins-were enriched in this ER-containing fraction ( Figure 2E ). In addition, the abundance of KDEL motif-containing proteins, as well as actin, was lower in the MEJ fraction compared to the EGC fraction, indicating that the MEJ fraction is indeed enriched for ER membranes located at contact sites with mitochondria ( Figure 2E ). Together, these experiments established these MEJ fractions as a valid source to probe for proteins localized to mitochondria-ER junctions in cells with low abundance of mitochondria-ER contact sites. To validate by genetic means the role of mitochondria-ER contacts in controlling mitochondrial function in lymphocytes, Jurkat T cells were transiently transfected with siRNA directed against GRP75 or with a non-targeting scrambled control siRNA. GRP75 knockdown efficiency was approximately 50% (Figure 2F) , and there was no detectable difference in cell viability ( Figure S2F ). In agreement with the effect of microtubule depolymerization on abundance of mitochondria-ER contact sites in EM CD8 + T cells and Jurkat T cells, mitochondria-ER contacts were significantly reduced in GRP75-depleted cells ( Figure 2G ). GRP75 knockdown also resulted in a marked decrease in mitochondrial respiration, while it did not impact glycolysis (Figure 2H) . Together, these results demonstrated that mitochondrial respiration in newly activated memory T cells, as well as in Jurkat T cells, was intricately tied to their physical association with the ER.
The mTORC2-AKT-GSK3b Signaling Pathway Is Activated at Mitochondria-ER Contact Sites mTORC2 and Akt can localize to mitochondria-ER contact sites in mouse hepatocytes and mouse embryonic fibroblasts (Betz et al., 2013) . Since mTORC2-AKT signaling is essential for the rapid recall response, we thus hypothesized that mTORC2 and AKT are present in mitochondria-ER contact sites of memory CD8 + T cells and are activated following TCR and CD28 stimulation. To test this hypothesis, we first probed the global expression of mTORC2 components-mTOR, RICTOR, and SIN1-in human naive and EM CD8 + T cells. We detected no difference in total cellular abundance of these proteins in both subsets (Figure S3A ). Next, we probed for mTOR, RICTOR, RAPTOR, and AKT localization in MEJ, PM, and EGC fractions, as well as in total cell lysates (T) of Jurkat T cells ( Figure 3A) . mTOR, RICTOR, and AKT were detected in all fractions, with AKT being notably less abundant in pure mitochondria fractions as compared to MEJ fractions ( Figure 3A ). We then interrogated whether mTORC2 was also present in the MEJ fraction of sorted naive and EM CD8 + T cells, directly ex vivo. Similar to Jurkat T cells, mTOR and RICTOR were detected in the MEJ fraction of both EM and naive CD8 + T cells ( Figure 3B ). This indicated that mitochondria-ER contact sites of naive CD8 + T cells, while much less abundant ( Figures 1B-1D ), were not qualitatively different with regards to the presence of mTOR and RICTOR, and that mTORC2 was present by default in this subcellular region. To ensure that mTORC2 remained in the mitochondria-ER junction of activated T cells, we assessed the same subcellular fractions from non-activated versus a-CD3 and a-CD28 mAb-activated CD8 + T cells. Due to limitations with regard to available amounts of human cells, these experiments had to be performed with bulk CD8 + T cells. Both mTOR and rictor were similarly detected in the mitochondria-ER fraction of non-activated and activated cells ( Figure 3C ). mTORC2 is the primary kinase that mediates AKT-Ser473 phosphorylation. As previously demonstrated, AKT is phosphorylated at Ser473 only in nascent activated EM CD8 + T cells, but not in similarly activated naive counterparts ( Figure S3B ; Gubser et al., 2013) . To further define the role of mTORC2 in the activation of Akt at mitochondria-ER junctions, we examined AktSer473 phosphorylation in OT-I TCR transgenic, Rictor-deficient murine CD8 + T cells (Rictor flox/flox : Cd4-Cre + xOT-I) (Zhang et al., 2016 Figure 3D ). Confirming the specificity of reduced mTORC2 activity, phosphorylation of AktThr308, a target of phosphoinositide-dependent kinase 1 (Pdk1), was unaltered, and in some experiments even higher in MEJ fractions from activated rictor -/-cells ( Figure 3D ).
We then assessed the requirement of an intact mTORC2-AKT signaling axis for mitochondrial metabolic reprogramming. The increase in mitochondrial respiration following aCD3 and aCD28 mAb stimulation was diminished in cells pre-treated with either mTOR (OSI-027 and KU-0063794) or AKT (Akti1/2 and MK-2206) inhibitors ( Figures 3E and 3F ). We then tested the impact of dissociating mitochondria-ER contacts on AKT activation. To that end, EM CD8 + T cells were activated in presence or absence of nocodazole, and whole-cell lysates were assessed for AKT phosphorylation at Ser-473 ( Figure 3G ). Dissociation of mitochondria-ER contacts largely prevented AKT phosphorylation, indicating that intact mTORC2-AKT activity in this subcellular compartment was required for increased mitochondrial respiration of newly activated EM CD8 + T cells. GSK3b is an AKT1 target that was previously demonstrated to impact glycolysis and glucose oxidation in mitochondria of nonimmune cells (Pastorino et al., 2005) . AKT-mediated phosphorylation of Ser9 inhibits the kinase activity of GSK3b (Cross et al., 1995) . GSK3b Ser9 phosphorylation was increased in activated EM cells but only to a lesser extent in activated naive cells (Figure S3C) . In addition, using a screen for phosphorylated AKT substrate motifs (RXRXXS*/T*), a band in the 40-50 kD region, which is the size range of GSK3b, was noticeably increased (C) Immunoblot analysis of EGC and MEJ fractions from bulk CD8 + T cells treated with non-loaded control beads (-) or activated with a-CD3 and a-CD28 mAb-loaded beads (+) for 2 hr. Blots were probed with mTOR and RICTOR antibodies. Cox IV was used as fraction validation control (representative of n = 3 independent experiments).
(D) Left, immunoblot analysis of MEJ fractions from wild-type (WT) and rictor KO memory CD8 + T cells re-stimulated with OVA peptide for 1 hr (+) or from non-activated counterparts (-). Blots were probed for total Akt, pAkt-S473, pAkt-T308, and Cox IV. Right, quantification was performed by normalization of targets to Cox IV. Bar graphs show fold change in Akt phosphorylation following activation relative to non-activated controls (n = 3 independent experiments).
(E and F) Summary of metabolic flux analysis on EM CD8 + T cells activated and assayed as in Figure 1A . Cells were treated with inhibitors of mTOR (OSI-027, 10 mM, and KU0063794, 10 mM) (E) or AKT (Akti, 10 mM, and MK2206, 10 mM) (F). Bar graphs show basal and maximal respiration (n = 4-8 donors).
(G) Immunoblot analysis of total cell lysates from EM CD8 + T cells activated for 2 hr with a-CD3 and a-CD28 mAb loaded beads only or similarly activated in presence of nocodazole (10 mM). Bar graph shows AKT-Ser473 phosphorylation normalized to actin (n = 3 independent experiments).
(H) Immunoblots of MEJ and PM fractions from Jurkat T cells. Blots were probed with GSK3b and COX IV antibodies (representative of n = 3 independent experiments).
(I) Immunoblots of MEJ and EGC fractions from bulk CD8 + T cells either left unstimulated (-) or activated (+) with a-CD3 and a-CD28 mAb-loaded beads for 2 hr.
Blots were probed for total GSK3b, pGSK3b Ser9, and COX IV (representative of n = 3 donors).
(J) Left, immunoblot analysis of WT and rictor KO memory OT-I cells activated as in (D). MEJ fractions were probed for Gsk-3b, pGsk-3b Ser9, and Cox IV. Right, bar graphs display fold change in phosphoprotein levels relative to non-activated controls (n = 3 independent experiments). Data are presented as mean ± SEM. Two-tailed paired Student's t test (D-G, J) were used to compare groups. *p < 0.05, **p < 0.01, ns, not significant. See also Figure S3 . (E) Left, representative mitochondrial perturbation assay of human EM CD8 + T cells activated as in Figure 1A in the presence of dNP2 peptide (5 mM), or activated in the presence of dNP2-VDAC peptide for 12 hr (5 mM). Right, summary bar graphs of basal respiration and glycolysis (n = 3 donors).
(F) Left, representative mitochondrial perturbation assay using Jurkat T cells treated with dNP2 peptide (5 mM) or dNP2-VDAC peptide (5 mM) for 12 hr. Right, summary bar graphs of basal respiration and glycolysis (n = 3 independent experiments).
(G) Oxygen consumption rates of permeabilized Jurkat T cells treated as in (D). Cells were permeabilized and respiration was assessed after addition of pyruvate, malate, and ADP (indicated as ''compounds'' on the graph) (representative of n = 2 independent experiments).
(legend continued on next page) in activated EM CD8 + T cells but not in activated naive cells (Figure S3D) . Together, these findings demonstrated that GSK3b activity was diminished in newly activated EM CD8 + T cells.
We then proceeded to examine the subcellular localization of GSK3b in T cells. First, we assessed MEJ and PM fractions from Jurkat T cells. Similar to AKT ( Figure 3A ), GSK3b was readily detected in MEJ fractions from Jurkat T cells, where it was more abundant than in pure mitochondria lysates ( Figure 3H ). We then investigated whether GSK3b was also present at mitochondria-ER junctions of primary human CD8 + T cells. As shown in Fig- ure 3I (upper lane), GSK3b was detected in MEJ fractions of both non-activated and activated CD8 + T cells. In addition,
GSK3b was also detected in mitochondria and ER-rich regions by confocal microscopy ( Figure S3E ). GSK3b phosphorylation at Ser9 was increased in the MEJ fraction of activated human CD8 + T cells ( Figure 3I , middle lane). In addition, using WT and rictor -/-OT-I cells, Gsk-3b Ser9 phosphorylation in the MEJ fraction was diminished in rictor -/-cells upon TCR stimulation by approximately 50% ( Figure 3J ). These data demonstrated that intact mTORC2 activity at mitochondria-ER interaction sites was important for Gsk-3b phosphorylation at Ser9. Thus, it is plausible that impaired Akt-Ser473 phosphorylation in rictor -/-memory T cells led to deficits in Akt activity and thus reduced phosphorylation of Gsk-3b at Ser9 in mitochondria-ER junctions. These findings indicated that mitochondria-ER appositions functioned as a hub for mTORC2-AKT-GSK3b signaling during memory CD8 + T cell recall responses.
HK-I Binding to VDAC Controls Mitochondrial Metabolism in T Cells
We went on to relate mTORC2-AKT-GSK3b signaling at mitochondria-ER contact sites with the mitochondrial reprogramming uniquely observed in newly activated memory CD8 + T cells. VDAC is a GSK3b target found at the outer mitochondrial membrane, which is abundant at mitochondria-ER appositions. In HeLa cells, GSK3b-mediated phosphorylation of VDAC inhibits hexokinase binding (Pastorino et al., 2005) . Therefore, we assessed HK abundance in MEJ fractions of quiescent and activated human CD8 + T cells. HK-II was not detected in total lysates from bulk CD8 + T cells (data not shown). However, HK-I was enriched in MEJ fractions upon CD8 + T cell activation ( Figure 4A ) In addition, destabilization of mitochondria-ER contacts following treatment with nocodazole attenuated HK-I recruitment to mitochondria in activated CD8 + T cells (Figure 4B ). Combined, a molecular framework emerged, where stable mitochondria-ER contacts support mTORC2-AktGSK3b signaling, which in turn allows recruitment of HK-I to mitochondria.
To further elaborate on the impact of HK-I binding to VDAC on mitochondrial respiration, we examined metabolic remodeling in EM CD8 + T cells that were activated in the presence of drugs (clotrimazole and bifonazole) that block HK binding to VDAC (Penso and Beitner, 1998) . Clotrimazole and bifonazole treatment did not affect aerobic glycolysis in EM CD8 + T cells activated for 12 hr ( Figures 4C and S4A ). However, mitochondrial respiration was clearly muted in the presence of either compound ( Figures 4C and S4A) . Moreover, clotrimazole pre-treatment did not attenuate the activation-induced early and stable glycolytic switch characteristic of EM CD8 + T cells ( Figure S4B ),
indicating that HK-I activity in nascent activated memory CD8 + T cells was independent of its subcellular localization and accessibility to mitochondrial ATP (van der Windt et al., 2013) . Congruent with these experiments, clotrimazole also inhibited respiration in Jurkat T cells while leaving glycolysis largely unaffected ( Figure 4D ). We then proceeded to specifically block HK-I binding to VDAC by using cell-penetrating VDAC1-based peptides that were N terminally linked to dNP2, a 22-residue-long cell-penetrating peptide from the human novel LZAP-binding protein (NLBP) (Arzoine et al., 2009; Lim et al., 2016) . In agreement with the findings in Figures 4 and S4A , hindering HK-VDAC interactions using dNP2-VDAC peptides attenuated mitochondrial respiration in activated EM CD8 + T cells ( Figure 4E) as well as in Jurkat T cells ( Figure 4F ), whereas glycolysis remained largely unaffected ( Figures 4E and 4F ). This reduction in mitochondrial metabolism was not due to increased cell death, since cellular viability was similar between dNP2 controls and dnP2-VDAC-treated cells ( Figure S4C ). Next, we proceeded to assess the direct effect of HK-I binding to VDAC on mitochondrial respiration by using permeabilized T cells. Mitochondria from permeabilized control Jurkat T cells were able to enhance respiration following addition of excess ADP, pyruvate, and malate (state III ADP respiration) ( Figure 4G ). By contrast, cells pre-treated with clotrimazole were unable to increase state III ADP respiration. The unresponsiveness of clotrimazole-treated Jurkat T cells to state III metabolites suggested that blockade of HK binding to VDAC altered VDAC conductance for substrates used either in ATP turnover or substrate oxidation (Brand and Nicholls, 2011) . Next, we evaluated the direct effect of clotrimazole on mitochondrial respiration in CD8 + T cells. For these assays, we examined oxygen consumption of permeabilized, pre-activated human EM CD8 + T cells in the presence of oligomycin, malate, and pyruvate. Control cells increased oxygen consumption upon addition of substrates, whereas concomitant addition of clotrimazole decreased oxygen consumption ( Figure 4H ). These results suggested that HK-I binding to VDAC in memory CD8 + T cells altered VDAC conductance of substrates that are important for supporting mitochondrial respiration.
Glucose Is Metabolized in the Mitochondria of Activated EM CD8 + T Cells
Aerobic glycolysis generates pyruvate that is either converted to lactate or oxidized in the TCA cycle. Thus, we examined how 13 C 6 -glucose glucose is metabolized in memory CD8 + T cells immediately after activation. Consistent with our previous findings (Gubser et al., 2013) , glucose-derived lactate (M+3) was (H) Oxygen consumption of permeabilized human EM CD8 + T cells activated as in Figure 1A for 12 hr. Cells were then permeabilized and treated with malate, pyruvate, oligomycin, and DMSO/clotrimazole (25 mM), and changes in OCR were assessed relative to pre-injection rates (representative of n = 2 donors). Data are presented as mean ± SEM. Two-tailed paired Student's t test (B-F) were used to compare groups. *p < 0.05, **p < 0.01, ns, not significant. See also Figure S4 .
significantly increased following activation ( Figure 5A ). Moreover, glucose-derived isotopologues of citrate (M+2, M+3, M+4), malate (M+2, M+3), and aspartate (M+2, M+3) were also increased ( Figure 5A ). This established that tricarboxylic acid (TCA) cycle activity in EM CD8 + T cells was rapidly enhanced following activation. We then proceeded to define, in more detail, the impact of AKT on mitochondrial metabolism by utilizing an unbiased global metabolomic profiling approach. Congruent with the glucose tracing experiments shown in Figure 5A , most differentially abundant metabolites in activated CD8 + T cells were part of the glycolytic pathway and the TCA cycle (Figure 5B) . Specifically, the glycolytic metabolites fructose 1,6 bisphosphate (F1,6P), 3-phosphoglycerate (3PG), phosphoenol pyruvate (PEP), and lactate were elevated in activated EM but not in naive CD8 + T cells ( Figure 5B ). In addition, TCA cycle metabolites (citrate, malate, and, to some extent, fumarate) were also selectively increased in activated EM cells ( Figure 5B ). Upon pre-treatment with Akti, all glycolytic and TCA cycle metabolites that were differentially increased in activated EM CD8 + T cells remained at baseline levels ( Figure 5B ). The abundance of metabolites along other pathways were unaffected by AKT inhibition. This was true for metabolites from pathways that did not change activity upon T cell activation (e.g., ascorbate, glutathione), as well as for metabolites from pathways that altered activity in stimulated cells (e.g., carnitine, acetylcarnitine) ( Figure S5A ). The observed reduction in glycolytic and TCA cycle metabolites following AKT inhibition could be due to a reduction in glucose uptake. As expected, glucose uptake in the presence of Akti was lower in activated EM cells compared to activated controls. However, glucose uptake in Akti-treated activated cells was still greater than non-stimulated counterparts ( Figure S5B ). These findings indicated that, in addition to its already established role in directing glucose uptake and glycolysis, another key function of the mTORC2-AKT signaling axis in nascent activated EM CD8 + T cell was enhancement of glucose oxidation in mitochondria. (a-CD3 and a-CD28 mAb-loaded beads) conditions for 6 hr in 13 C-glucose-containing media. Bar graphs display mass isotopologue distribution of incorporated 13 C. M+0 bars represent fractions of metabolites with no 13 C-glucose incorporation (n = 4-5 donors).
(B) Glycolysis and TCA cycle metabolites in NV and EM CD8 + T cells stimulated with a-CD3 and a-CD28 mAb-loaded beads for 2 hr. Metabolites from EM CD8 + T cells (±activation) treated with Akti (10 mM) were further assessed. Box and whisker graphs reflect abundance of glucose-6-phosphate (G6P), fructose-1,6-bisphosphate (F1,6P), 3-phosphoglycerate (3PG), phosphoenolpyruvate (PEP), lactate, citrate, fumarate, and malate in all samples tested (n = 5 donors). Data are represented as mean ± SEM (A) and median ± min/max (B). Two-tailed paired Student's t test (A) and ANOVA contrasts (B) were used to compare groups. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S5 .
Enhancement of Mitochondrial Metabolism Driven by Mitochondria-ER Junctions Is Important for the Rapid Recall Response of Memory CD8 + T Cells
Given the selective enhancement of mitochondrial respiration in newly activated memory CD8 + T cells, we interrogated whether the membrane-permeable form of pyruvate (methyl pyruvate, MePyr) could rescue IFN-g production in cells treated with the glycolysis inhibitor, 2-deoxyglucose (2-DG). As expected, treatment with 2-DG decreased IFN-g production of activated EM CD8 + T cells ( Figure 6A ). However, addition of increasing doses (H) IFN-g production by EM CD8 + T cells activated with a-CD3/a-CD28 mAb-loaded beads for 12 hr ± ETC inhibitors (n = 7-9 donors).
(I) ATP measurement in EM CD8 + T cells with no stimulation or activated with a-CD3 and a-CD28 mAb-loaded beads ± FCCP (5 mM) or oligomycin (Oligo, 0.1 mM)
for 12 hr, (n = 5 donors).
(J) IFN-g production by EM CD8 + T cells activated as in (B) in the presence of the uncoupling agent FCCP (5 mM) ± UK5099 (10 mM) (n = 5-7 donors).
(K) IFN-g production by EM CD8 + T cells activated as in (B) in the presence of the ACLY inhibitor SB-204990 (3 mM) (n = 5 donors).
Data are presented as mean ± SEM. Two-tailed paired Student's t tests were used throughout to compare groups. *p < 0.05, **p < 0.01, ***p < 0.001, ns, not significant. See also Figure S6 .
of MePyr fully circumvented the inhibitory effect of 2-DG on IFN-g production ( Figure 6A ). Pyruvate sits at a metabolic branch point, since it is either metabolized in the TCA cycle or converted to lactate. Thus, we examined the impact of pyruvate dehydrogenase (PDH) or lactate dehydrogenase (LDH) inhibition on IFN-g production. CPI-613, a PDH inhibitor, reduced IFN-g production in activated EM CD8 + T cells ( Figure 6B ). Inhibition of lactate dehydrogenase with oxamate did not consistently and significantly affect IFN-g production ( Figure 6C ). These results established that metabolism of glucose-derived pyruvate in the mitochondria was required to optimally support the rapid recall response of EM CD8 + T cells.
We then interrogated the role of mitochondria-ER interactions in potentiating the immediate-early EM CD8 + T cell recall response. Rapid IFN-g production was prevented in nocodazole-treated EM CD8 + T cells ( Figure 6D ). In addition, inhibiting recruitment of HK-I to the mitochondria by clotrimazole or bifonazole also reduced IFN-g production ( Figure 6E ). IFNG transcripts were likewise reduced in both nocodazole-and clotrimazole-treated cells ( Figure S6A ). Viability of EM CD8 + T cells was not affected by either nocodazole or clotrimazole ( Figure S6B ). Lastly, blockade of HK-I and VDAC interaction using the cellpenetrating peptide dNP2-VDAC also reduced IFN-g production ( Figure S6C ). Given these findings, we postulated that reduced IFN-g production in AKT-inhibited, activated EM CD8 + T cells should be rescued by direct pharmacologic inhibition of GSK3b. In agreement with our previous experiments, AKT inhibition reduced IFN-g gene transcription and protein production by EM T cells ( Figures S6D and 6F ). Combined treatment of cells with both Akti and the GSK3b inhibitor, TCS-2002, completely rescued IFN-g production at the transcriptional and partially at the protein level ( Figures S6D and 6F ). Together, these results established that mTORC2-AKT-GSK3b signaling at mitochondria-ER junctions contributed to the rapid recall response of memory CD8 + T cells by promoting HK-I binding to VDAC, and enhancing VDAC conductance for cytoplasmic metabolites that drive mitochondrial respiration. Since fueling of the TCA cycle by pyruvate was a key requirement for the early response of EM CD8 + T cells, we asked which aspect of mitochondrial function was required to support rapid IFN-g production. Therefore, EM CD8 + T cells were activated in the presence of various mitochondrial respiration modulators ( Figure 6G ) and then probed for effects on proliferation (Figure S6E) , activation (CD69) ( Figure S6F ), and IFN-g production ( Figure 6H ). Inhibitors that targeted mitochondrial electron transport chain (ETC) complexes I (rotenone), II (TTFA), III (antimycin-A), and V (oligomycin) all blocked cell proliferation ( Figure S6E ) but had little or no effect on CD69 cell surface expression (Figure S6F ). This indicated that inhibition of mitochondrial respiration had a limited impact on early activation but it efficiently prevented cell proliferation, potentially due to the reduction of ATP availability. All ETC complex inhibitors reduced IFN-g production at the protein and transcriptional level ( Figures 6H and S6G ), which demonstrated that maintaining electron transport function was an important aspect of the rapid recall response. Of note, none of the ETC inhibitors used in these experiments affected cell viability ( Figure S6B ). Next, we assessed the impact of dissipating the mitochondrial proton gradient on IFN-g production by using the mitochondrial uncoupler FCCP. Similar to the effect of ATP synthase inhibition with oligomycin, chemical uncoupling of the proton gradient diminished ATP production ( Figure 6I ). We hypothesized that, if deficits in ATP synthesis following inhibition of the ETC led to a decrease in IFN-g production, then chemical uncoupling of the proton gradient should mimic this effect. Analogous to the inhibition of ETC complexes, chemical uncoupling of mitochondrial respiration had little impact on CD69 expression yet it blocked EM CD8 + T cell proliferation (data not shown).
However, in contrast to ETC inhibition, disruption of the electrochemical gradient did not inhibit IFN-g production ( Figure 6J ). Lastly, co-treatment of cells with mitochondrial pyruvate carrier inhibitor UK5099 and FCCP significantly reduced their capacity to produce IFN-g ( Figure 6J ). This demonstrated that that mitochondrial pyruvate oxidation, and not ATP synthesis, was a key driver of early IFN-g production.
We previously demonstrated that acetylation of H3K9 at the IFNG promoter is dependent on glycolysis (Gubser et al., 2013) . Conversion of glucose-derived citrate into acetyl-CoAwhich then can be used for histone acetylation-is mediated by the enzyme ATP citrate-lyase (ACLY) (Wellen et al., 2009) . Indeed, treatment of activated EM CD8 + T cells with SB-204990, an ACLY inhibitor, attenuated IFN-g production (Figure 6K ). In line with this finding, exposure to histone acetyltransferase inhibitors also reduced IFN-g production in these cells ( Figure S6H ). We also examined the impact of mitochondrial ROS and mitochondrial calcium uptake on IFN-g production by treating activated EM CD8 + T cells with mitochondria targeted anti-oxidant (mitotempo, MTP) or with mitochondrial calcium uniporter (MCU) inhibitors-Ru360 and ruthenium red (RR). Targeting either mitochondrial function did not impact IFN-g production ( Figures S6I and S6J) . In all, these data established that immediate-early IFN-g production by EM CD8 + T cells was not linked to mitochondrial ATP synthesis, ROS signaling, or calcium buffering; rather, enhanced respiration in EM CD8 + T cells increased the abundance of glucose-derived citrate for generation of acetyl-CoA by ACLY and subsequent histone acetylation.
Rictor Deficiency Attenuates the Rapid Recall Response of Memory CD8 + T Cells In Vitro and In Vivo Having observed increased abundance of mitochondria-ER contacts in human and murine CD8 + T cells and mTORC2 being localized to this subcellular structure, we next assessed whether IFN-g production by mouse memory OT-I cells was similarly dependent on mTORC2 following re-stimulation with its cognate peptide (OVA) or with altered peptide variants possessing lower TCR affinities (OVA > R7 > G4). Rapid IFN-g production of in vitro differentiated rictor -/-memory OT-I cells was lower than in WT counterparts across all TCR:peptide affinities tested ( Figure 7A ). These differences in immune functionality were not due to the altered differentiation or cellular activation of rictor-deficient memory cells, since differentiation and activation markers (CD44, CD127, CXCR3, Ly6C, CD62L, KLRG1, CD27, CD25, CD69, CX3CR1, and CCR7) were all similarly expressed by WT and rictor -/-memory cells ( Figure S7 ). We further examined whether the reduction in IFN-g production by rictor-deficient memory cells in vitro also translated to reduced immune function in vivo. To that end, rictor -/-and WT memory OT-I cells were adoptively transferred into mice, which were infected with LmOVA at 24 hr post-transfer ( Figure 7B ). At 4 hr post-infection, we evaluated serum cytokine concentrations (IFN-g, TNF), and at 24 hr post-infection bacterial loads were assessed in the spleen and liver. IFN-g serum concentrations were markedly reduced in infected mice that received rictor -/-memory cells ( Figure 7C ). Additionally, the bacterial burden in the liver was significantly elevated in mice that received rictor -/-memory OT-I cells ( Figure 7D ). These findings confirmed the importance of mTORC2 activation in memory CD8 + T cells during the very early phase of the recall response. In summary, our data identified compartmentalized metabolic reprogramming in memory CD8 + T cells. Specifically, we demonstrated the selective abundance of mitochondria-ER junctions in memory CD8 + T cells. This subcellular compartment was a hub that, by default, brought together signaling molecules necessary for rapid glycolytic remodeling and enabled recruitment of HK-I to VDAC. Binding of HK-I to VDAC supported mitochondrial import of metabolites needed for respiration. Oxidation of glucose in the mitochondria was the metabolic requirement for rapid production of IFN-g, potentially by providing substrates for histone acetylation.
DISCUSSION
Using a combination of imaging, biochemical, metabolic, and immunologic methods, our study demonstrates that mitochondria-ER contacts are key drivers of rapid metabolic and functional reprogramming in memory CD8 + T cells. We show that mitochondria-ER contacts are enriched in memory CD8 + T cells and required for enhancement of mitochondrial respiration in newly activated cells. In a preformed manner mTORC2, AKT, and GSK3b were present in this subcellular compartment of non-activated memory CD8 + T cells, and activation-induced signaling activity of this pathway in mitochondria-ER junctions was essential for recruitment of HK-I to the mitochondria via binding to VDAC. HK-I binding was important for enhancing mitochondrial respiration in newly activated memory T cells, which we further identified as a requirement for rapid IFN-g production.
We previously demonstrated that histone 3, lysine 9 (H3K9) acetylation in the IFNG promoter is increased following activation of EM CD8 + T cells (Gubser et al., 2013) . Acetyl-CoA used for acetylation of histones is primarily derived from glucose oxidized in the mitochondria (Wellen et al., 2009) . We now show that glucose-derived citrate, the primary metabolite exported from mitochondria and converted to acetyl-CoA by ATP citrate lyase, was abundant in activated EM CD8 + T cells, but not in Akt-inhibited counterparts. Preventing acetyl-CoA formation from citrate and blocking histone acetyl-transferase activity both reduced the capacity of nascent activated EM CD8 + T cells to produce IFN-g. Moreover, dissociation of mitochondria-ER contacts, inhibition of mTORC2-Akt signaling, and dissociation of HK-I from mitochondria all negatively impacted the selective enhancement of mitochondrial respiration and IFN-g production in nascent activated EM CD8 + T cells. Therefore, these findings point to mitochondria-ER junctions as a hub bringing together signaling and metabolic components that potentiate glucose oxidation, mitochondrial respiration, and citrate production in newly activated EM CD8 + T cells to enable the rapid recall response. Increased calcium in the mitochondrial matrix is known to potentiate respiration by enhancing the function of TCA cycle dehydrogenases (Denton, 2009 ). Mitochondria-ER interactions can directly influence mitochondrial metabolism by regulating calcium flux via the VDAC-mitochondrial calcium uniporter complex (Raturi and Simmen, 2013) . Here, i.e., in nascent activated memory CD8 + T cells, blocking calcium buffering did not influence rapid production of IFN-g, suggesting that mitochondria-ER junctions in T cells were not essential to this process. HK-VDAC interaction can modulate mitochondrial outer membrane (OMM) conductance to small molecules (organic phosphate) and ions (Ca 2+ ) (Shoshan-Barmatz and Mizrachi, 2012). However, the impact of this interaction on conductance of metabolites, such as ADP, pyruvate, and malate, is not well established. Our results show that dissociation of HK-I from the mitochondria did not affect cell-wide aerobic glycolysis early after activation, but reduced mitochondrial respiration. We further show that oxidation of glucose in the mitochondria was important in newly activated EM CD8 + T cells to support rapid cytokine production. By hindering HK-I binding to VDAC in permeabilized cells, we additionally provide evidence that HK-I binding to VDAC indeed augmented metabolite flux through the OMM, thereby promoting TCA activity and hence respiration. Thus, in this scenario, the recruitment of HK-I to VDAC linked the initial step of glycolysis to glucose oxidation (i.e., pyruvate oxidation) in the mitochondria.
NLRP3 inflammasome components in THP1 cells were previously shown to co-localize with mitochondria and ER (Zhou et al., Each dot represents data obtained from cells isolated from one mouse, bars indicate mean ± SEM. Two-tailed paired Student's t test were used to compare groups. *p < 0.05, **p < 0.01, ns, not significant. See also Figure S7. 2011). Moreover, HK is a pattern recognition receptor that mediates NLRP3 activation (Wolf et al., 2016) . Together, these findings suggest that mitochondria-ER interactions may also serve as a subcellular hub for immune cell inflammasome activation, potentially via the initial recruitment of HK-I to the mitochondria. In addition, since endogenous NLRP3 inflammasome activation was recently shown to control human Th1 cell responses following TCR/CD46 stimulation (Arbore et al., 2016) , it would be interesting to investigate whether this subcellular compartment is involved in T cell inflammasome activation.
In summary, our data uncovered that integrating ultrastructural aspects of the cell-such as the ER-mitochondria network-is vital to fully appreciate how the intersection of signaling and metabolic pathway usage impacts immune cell functionality.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Healthy blood donors Blood samples were obtained from healthy male and female donors (18-65 years old) as buffy coats after written informed consent (Blood donor center, University Hospital Basel).
Animals C57BL/6J mice were obtained from Jackson Laboratories. T cell specific Rictor-deficient mice were generated by crossing CD4 promoter controlled Cre recombinase transgenic mice with Rictor-deficient mice. T cell specific Rictor flox/flox : Cd4-Cre + mice were further crossed with OT-I TCR transgenic mice. Rictor À/À strains were backcrossed to the C57BL/6J background. Male and female mice between 16-24 weeks of age and same sex littermates were used for experiments. Mice were maintained at the specific pathogen free animal facilities at the University of Lausanne and at the University of Basel. All animal experiments were performed in accordance with local and Swiss federal guidelines.
Cell Lines
Jurkat T cells were cultured in R10FBS supplemented with 2 mM glutamine and maintained at 37 degrees Celsius with 5%C02.
METHOD DETAILS Human CD8 + T cell isolation and sorting
Peripheral blood mononuclear cells (PBMC) were isolated from male and female healthy donors by standard density-gradient centrifugation protocols (Lymphoprep Fresenius Kabi, Norway). CD8 + T cells were enriched by positive selection using magnetic CD8 + beads (Miltenyi Biotec, Germany). Cells were rested overnight prior to cell sorting in RPMI-1640 medium (GIBCO, USA) containing 10% fetal bovine serum (FBS, GIBCO, USA), 50U/ml penicillin and 50 mg/ml streptomycin (GIBCO, USA) (R10FBS). For sorting of naive and EM CD8 + T cells, CD8 + were stained with anti-CD62L (ImmunoTools, Germany) and anti-CD45RA (Beckman Coulter, USA) antibodies. NV and EM CD8 + T cells were identified as CD62L + CD45RA + and CD62L -CD45RA -populations, respectively. Cell sorting was performed with a BD influx cell sorter (BD Bioscience, USA). Cells were rested in R10FBS for 2-4 hours at 37 C prior to further experiments.
Mouse T cell isolation and culture Spleen and lymph nodes were removed from OT-I wt and Rictor -/-mice. Single cell suspensions from both tissues were activated with OVA peptide for 3 d and then cultured for an additional 3 d in IL-15 (10 ng/ml). Mouse OT-I cells were cultured in RPMI 1640 containing 10% FCS, 100 U/mL penicillin, 100 mg streptomycin, 0.29 mg/mL L-glutamine, 50 mM b-Mercaptoethanol. In vivo derived, OT-I memory T cells were isolated from L. monocytogenes infected mice (> 40 days post-infection) that were transferred with naive OT-I cells 24 hours before infection. T cells were isolated from splenocytes, and memory OT-I cells sorted using a BD influx cell sorter (BD Bioscience, USA).
T cell activation
Human CD8 + T cell activation was performed using in house generated anti-CD3/anti-CD28 coated microbeads unless indicated otherwise. Polybead microspheres (4.5 mm, Polyscience Eppenheim) were incubated with 10 mg anti-human CD28 IgG1 antibody (CD28.2 Biolegend, USA) and 1.5 mg anti-human CD3 IgG2a antibody (HIT3a, Biolegend, USA). Antibody coupling was tested using 2 nd antibodies against IgG1 or IgG2a (SouthernBiotech, USA), respectively. Quality control was performed by measuring the amount of antibody molecules per bead and using Quantum MESF microspheres (Bangslab, USA) for reference. All measurements were performed using a BD AccuriC6 flow cytometer (Becton Dickinson, USA) and data analyzed with FlowJo 10.0.8 software (Tree Star, USA). All bead based T cell activations were performed using a 2:1 bead to cell ratio. For 12 hour activation of human T cells used in metabolic flux assays, cells were activated with plate bound anti-CD3 (5 mg/ml, HIT3A) and soluble anti-CD28 (10 mg/ml) antibodies. For direct measurement of activation induced glycolytic switch by metabolic flux analysis, activation beads (5:1 bead to cell ratio) were directly added through the injection port. For in vitro reactivation of mouse T cells, memory OT-I cells were re-stimulated with 10 mM peptide ligands (OVA, R7, G4) for 1 hour (cell fractionation for immunoblots), or 4 hours (intracellular cytokine staining).
Adoptive transfer and bacterial infection 1x10 5 in vitro generated memory OT-I cells from wt or rictor KO mice were adoptively transferred intravenously (i.v.) into C57BL/6 mice. Recipient mice were then infected with 5x10 5 CFU virulent LmOVA-N4 at 24 hours post-transfer. Mice were bled at 4 hours post-infection to measure serum cytokines and sacrificed at 24 hours post-infection. Spleens and livers were removed and both organs were homogenized in 0.5% Tergitol/PBS with a Tissuelyser (QIAGEN). Organ suspensions were plated on brain-heartinfusion (BHI) and bacterial colonies counted at 24 hours after plating. non-activated and activated T cells according to the manufacturer's instructions.
Metabolic assays
IFN-g measurement EM CD8
+ T cells were plated on flat-bottom 96 well plates (3x10 5 cells/well) using R10FBS. In select experiments, cells were preincubated for 30 min. with inhibitors and then activated using anti-CD3/anti-CD28 loaded beads. Cell supernatants were harvested 12 hours after activation and IFN-g was measured using either an IFN-g ELISA kit (eBioscience, USA) or a human Th1 cytokine beadbased immunoassay (Legendplex, Biolegend) according to manufacterer's instructions. For cytokine measurements in mouse sera, a bead-based immunoassay was also used.
Metabolomics NV and EM CD8 + T cells were cultured for 2 hours in a 24 well plate (3x10 6 cells/well) under non-activating and activating conditions. For Akt inhibition, cells were treated with Akti1/2 (10 mM, Sigma-Aldrich). Cell pellets were washed twice with cold PBS, snap frozen in EtOH containing dry ice and stored at À80 C. Metabolomic assays and analysis were performed by Metabolon Inc. (Durham, USA).
Flow cytometry
For cell proliferation assays, EM CD8 + T cells were loaded prior to activation with the cell-proliferation dye carboxyfluorescein succinimidyl ester (1 mM CFSE, Molecular probes, USA) and seeded on 48-well plates (5x10 5 cells/well). Plated cells were pretreated with inhibitors as indicated, and cultured with activation beads and IL-2 (1000 U/ml) (ImmunoTools, Germany) for 3 days. For surface staining of CD8 + T cells, human T cells were stained with antibodies targeting CD8, CD3, CD45RA, CD62L, CD69, and mouse OT-I cells were stained with antibodies targeting CD69, CD44, CD127, CXCR3, Ly6C, CD62L, KLRG1, CD27, CD25, CD69, CX3CR1, and CCR7. For intracellular IFN-g measurements, cells were treated with Brefeldin A after 2 hours of activation and stained using a standard intracellular cytokine staining protocol (BD Bioscience). For measurement of mitochondrial mass and membrane potential, cells were stained with mitotracker green (MTG, 25 nM) or mitotracker red (MTR, 25 nM), respectively. Data was acquired using a BD AccuriC6 flow cytometer and analyzed with Flowjo 10.0.8 (Tree Star, USA).
Total cell lysate preparation and cell fractionation To prepare total cell lysates, cells were activated for 1 hour (beads or peptide). Cell pellets were washed with cold PBS and lysed using RIPA buffer (Thermo Scientific, Rockford IL, USA) containing protease and phosphatase inhibitors (Roche). To prepare mitochondrial fractions that are enriched in mitochondria-ER junctions, cells were washed and resuspended in homogenization buffer (225 mM mannitol, 75 mM sucrose, 0.1 mM EGTA and 30 mM Tris-HCl pH 7.4), and homogenized with 20 strokes (CD8 + T cells)
or 50 strokes (Jurkat T cells) using a teflon homogenizer. Cell homogenates were centrifuged twice at 600xg for 5 min. (4 C) and pellets were discarded after each spin. Supernatants were then centrifuged at 10'300xg, 10 min. (4 C). Supernatants (containing ER, Golgi and cytoplasm) were collected, and pellets (containing mitochondria-ER junction-enriched mitochondria) were resuspended in RIPA buffer (Thermo Scientific, Rockford IL, USA). A digitonin-based protocol using glass homogenizers was used to prepare pure mitochondrial fractions.
Immunoblots
Protein concentrations were determined by BCA protein assay kit (Thermo Scientific). Total cell lysates, cytoplasmic, mitochondria-ER junction-enriched mitochondrial fractions or pure mitochondrial fractions were separated using 4%-15% Mini Protean TGX Gel (Bio-Rad, Hercules CA, USA), and transferred to nitrocellulose membranes using Trans-Blot Turbo Transfer (Bio-Rad, Hercules CA, USA). Membranes were probed with antibodies against ACC, rictor, mTOR, HK-I, HK-II, Sin1, Cox iv, Akt, pAkt Thr308, pAkt Ser473, p-(S/T) Akt substrate motif, pGsk-3b Ser9 (all from cell signaling), GRP75, VDAC1, Gsk-3b (from Abcam), actin (Sigma-Aldrich), or raptor (Bethyl). Blots were stained with appropriate secondary antibodies and the odyssey imaging system (LICOR, Lincoln NE, USA) was used for visualization.
Electron microscopy
Transmission electron microscopy was performed at the Biozentrum (University of Basel). Cells were sequentially fixed in 3% paraformaldehyde, 0.5% glutaraldehyde and 1% osmium tetraoxide, embedded and then cut into 60 nm sections. Micrographs (27'000x magnification) were obtained with a Morgagni 268 (FEI, Hillsboro OR, USA) transmission electron microscope operated at 80 kV. ImageJ software (NIH, Bethesda, USA) was used for measuring mitochondrial length (major axis) and width (minor axis). To quantify the morphology of mitochondria, the average aspect ratio was calculated (major axis to minor axis), an aspect ratio of 1 indicates a circular mitochondrial section. To quantify mitochondria-ER contacts for each cell, total mitochondria and mitochondria in contact with ER were counted and the frequency of mitochondria-ER contacts calculated. Mitochondria-ER contacts were defined as mitochondria juxtaposed to ER at a distance of < 100 nM.
Proximity Ligation Assay
Anti-VDAC1 and anti-IP3R1 antibodies were used to visualize mitochondria-ER junctions. T cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and blocked with 5% goat serum. PLA was performed according to the manufacturer's instructions (Duolink, Sigma). Fluorescent spots were detected by using an inverted spinning disk confocal microscope, Visiscope CSU-W1 (Visitron). Quantification of detected spots per nucleus was performed by using the ImageJ software.
RNA mediated interference
Jurkat T cells were transfected with pools of Grp75 siRNA or control scrambled siRNA (QIAGEN) for 72 hours using the AMAXA T cell nucleofection kit (Lonza). Knockdown efficiency was verified by immunoblot analysis.
Confocal imaging
Experiments with fixed cells were performed on a Nikon A1 confocal microscope (Microscopy core facility, DBM) with a 40x oilimmersion objective. Cells were allowed to attach by gravity on culture slides (BD Bioscience) coated with poly-d-lysine for 20 min. Cells were pre-stained with mitotracker deep red and then fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. Cells were stained with antibodies against rictor (Atlas antibodies), KDEL motif (Abcam) or Gsk-3b (Abcam), labeled with the appropriate secondary antibodies, and counterstained with DAPI. All images were processed and analyzed using ImageJ (NIH). Experiments with live cells were performed using the 3I spinning disk confocal microscope (Intelligent Imaging Innovations, Denver CO, USA) with a 100x oil-immersion objective at 5% CO2 and 37 C (IMCF Facility, Biozentum, University of Basel). Cells were loaded with 50 nM MTG (Invitrogen) and 25 nM tetramethylrhodamine-ethyl-ester-perchlorate (TMRE, Invitrogen). Cells were incubated for 30 min. with both dyes, washed and resuspended in fresh media. Since CD8 + T cells are non-adherent, dyeloaded T cells were allowed to settle onto culture slides (Ibidi, Munich, Germany) coated with poly-d-lysine for 20-30 min. before imaging. Stacked images were then acquired at 0.5 mm intervals throughout the body of each cell. Quantification of mitochondrial structure was carried out on cells labeled with MTG. Extraction of mitochondrial structural parameters was performed using a multi-step image-processing algorithm. Briefly, MTG intensities in raw images were enhanced by linear contrast stretch, spatially process using a 7x7 top hat filter to isolate mitochondrial objects and converted into a binary image by a threshold operation. Mitochondrial circularity (4p area/perimeter 2 ), length, and form factor (1/circularity) were then calculated using ImageJ (NIH, Bethesda MD). Mitochondrial membrane potential (Dc m ) was calculated as the ratio of TMRE to MTG fluorescence intensities. MTG was included to normalize for mitochondrial mass differences between cell populations.
13
C 6 glucose labeling 2x10 6 EM CD8 + T cells were plated onto 48 well plates in RPMI10-FBS with 4 mM U-
C glucose and left non-activated or activated with anti-CD3/anti-CD28 loaded beads for 6 hours. Metabolites were extracted with 50% MeOH/30% Acetonitrile. Isotopologue distribution was assessed by LC-MS.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical significance was analyzed using Prism 6.0 (GraphPad Software, USA). P values of less than 0.05 were considered statistically significant.
